Swedish data support PCPT re-analysis: no increase in high-risk prostate cancer after use of 5-ARIs

Another study, just published in the British Medical Journal, appears to further debunk the idea that use of 5α-reductase inhibitors (5-ARIs) is associated with a significant increase in risk for development of high-grade prostate cancer. … READ MORE …